Head to Head Analysis: Hyperfine (HYPR) & Its Rivals

Hyperfine (NASDAQ:HYPRGet Rating) is one of 68 publicly-traded companies in the “Electromedical equipment” industry, but how does it contrast to its peers? We will compare Hyperfine to related businesses based on the strength of its institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings for Hyperfine and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine 0 1 2 0 2.67
Hyperfine Competitors 87 598 1654 76 2.71

Hyperfine presently has a consensus target price of $4.30, indicating a potential upside of 437.43%. As a group, “Electromedical equipment” companies have a potential upside of 82.72%. Given Hyperfine’s higher probable upside, equities research analysts clearly believe Hyperfine is more favorable than its peers.

Insider & Institutional Ownership

23.9% of Hyperfine shares are held by institutional investors. Comparatively, 44.7% of shares of all “Electromedical equipment” companies are held by institutional investors. 26.1% of Hyperfine shares are held by company insiders. Comparatively, 11.3% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Hyperfine and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hyperfine -1,479.40% -54.01% -49.87%
Hyperfine Competitors -712.65% -45.28% -25.88%

Volatility and Risk

Hyperfine has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, Hyperfine’s peers have a beta of 13.57, indicating that their average stock price is 1,257% more volatile than the S&P 500.

Earnings & Valuation

This table compares Hyperfine and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Hyperfine $1.50 million -$64.85 million -0.22
Hyperfine Competitors $1.05 billion $133.48 million 3.29

Hyperfine’s peers have higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Hyperfine peers beat Hyperfine on 11 of the 13 factors compared.

About Hyperfine

(Get Rating)

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.